New Tools in the Detection of Breast Cancer:
Molecular Breast Imaging, Tomosynthesis, Contrast Enhanced Spectral Mammography, and Magnetic Resonance Imaging
April 30, 2014
Houston Methodist Research Institute
6670 Bertner Avenue
LIVE WEBCAST WILL BE AVAILABLE
If you are unable to attend in person, you may watch the conference via a live webcast. Register by using the link below. A week before the conference, you will receive an email from Methodist CME with instructions for accessing and viewing the webcast. Please note that you will not receive CME credit for viewing the live webcast.
Luz A. Venta, MD, FACR, FSBI
Medical Director, Breast Imaging Program
Houston Methodist Hospital
Professor of Clinical of Radiology
Weill Cornell Medical College
Stephen W. Phillips, MD, FACR
Director of Breast Imaging and Intervention
Houston Methodist Sugarland Hospital
Assistant Professor of Radiology
Weill Cornell Medical College
For the first time in the last 20 years, the year 2013 saw FDA approval of new modalities for breast cancer detection: molecular breast imaging (MBI), digital breast tomosynthesis (DBT) and contrast enhanced spectral mammography (CESM). There is a need to educate physicians about the indications for these technologies as well as the radiologists as to how best to interpret these tools in their clinical practice. The strengths and weaknesses of each new technology will be reviewed as well as the current indications so that physicians will know when to order these exams for their patients and improve breast cancer detection.
Radiologists, gynecologists, general practitioners, internists, surgeons, plastic surgeons, radiation therapists, oncologists, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved with breast imaging.
At the conclusion of this activity, the participant should be able to:
- Describe current uses and indications for new technologies
- Provide attendees with criteria on how to detect breast cancer with MBI, DBT and CESM
- Review workflow issues regarding the adoption of MBI,CESM and DBT into clinical practice
ACCREDITATION AND CREDIT DESIGNATATION STATEMENTS
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This Live activity, New Tools in the Detection of Breast Cancer: Molecular Breast Imaging, Tomosynthesis, and Contrast Enhanced Spectral Mammography, with a beginning date of 04/09/2014, has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Nurses
Houston Methodist is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
FEES, REGISTRATION, AND CONFERENCE INFORMATION
Refer to the registration form for the fee schedule. Your registration will not be processed until payment is received. Your registration will be confirmed. If you have not received confirmation at least five business days before the activity start date, contact the Office of Continuing Medical Education (OCME) immediately.
If you plan to register on-site, contact OCME at least 24 hours in advance to confirm activity status and space availability. The OCME reserves the right to limit the number of participants in an activity and will not be responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.
This CME activity is designed for use by health care professionals for educational purposes only. Information and opinions offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.
Houston Methodist makes every effort to have accurate information presented; no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
In compliance with the Americans with Disabilities Act, Houston Methodist will make reasonable efforts to accommodate persons with disabilities at this symposium. Please call 713.441.4971 for further information, or if you need special assistance.
Office of Continuing Medical Education
6565 Fannin St., MGJ9-004 | Houston, TX 77030
Phone: 713.441.4971 | Fax: 713.441.0589